102 related articles for article (PubMed ID: 21438795)
1. Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US.
Stephenson JJ; Chang CL; Devecchis Wygant G; Hauch O; Cziraky MJ
Curr Med Res Opin; 2011 Jun; 27(6):1079-87. PubMed ID: 21438795
[TBL] [Abstract][Full Text] [Related]
2. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.
Ho PM; Tsai TT; Wang TY; Shetterly SM; Clarke CL; Go AS; Sedrakyan A; Rumsfeld JS; Peterson ED; Magid DJ
Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):303-8. PubMed ID: 20354221
[TBL] [Abstract][Full Text] [Related]
3. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.
Ho PM; Peterson ED; Wang L; Magid DJ; Fihn SD; Larsen GC; Jesse RA; Rumsfeld JS
JAMA; 2008 Feb; 299(5):532-9. PubMed ID: 18252883
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
Feldman DN; Fakorede F; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2010 Feb; 105(3):323-32. PubMed ID: 20102943
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
Wiederkehr D; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Corbelli J
Curr Med Res Opin; 2009 Sep; 25(9):2327-34. PubMed ID: 19635046
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Zhu B; Zhao Z; McCollam P; Anderson J; Bae JP; Fu H; Zettler M; Lenarz L
Curr Med Res Opin; 2011 Mar; 27(3):633-41. PubMed ID: 21241206
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ
Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption.
Johnston SS; Bell K; Gdovin J; Jing Y; Graham J
Hosp Pract (1995); 2012 Feb; 40(1):15-23. PubMed ID: 22406879
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
Tricoci P; Roe MT; Mulgund J; Newby LK; Smith SC; Pollack CV; Fintel DJ; Cannon CP; Bhatt DL; Gibler WB; Ohman EM; Peterson ED; Harrington RA
Arch Intern Med; 2006 Apr; 166(7):806-11. PubMed ID: 16606819
[TBL] [Abstract][Full Text] [Related]
11. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.
Berger JS; Frye CB; Harshaw Q; Edwards FH; Steinhubl SR; Becker RC
J Am Coll Cardiol; 2008 Nov; 52(21):1693-701. PubMed ID: 19007688
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
13. Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes.
Krimly A; Yan RT; Yan AT; DeYoung JP; Gallo R; Steg G; Eikelboom J; Gore JM; Fox KA; Fitchett D; Quantz MA; Goodman SG
Can J Cardiol; 2011; 27(6):711-5. PubMed ID: 21875778
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
Banerjee S; Varghese C; Samuel J; Weideman RA; Little BB; Kelly KC; Rao SV; Reilly RF; Brilakis ES
Am J Cardiol; 2008 Nov; 102(9):1159-62. PubMed ID: 18940284
[TBL] [Abstract][Full Text] [Related]
15. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
16. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel loading doses and outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Wang C; Kereiakes DJ; Bae JP; McCollam P; He J; Griffin B
J Invasive Cardiol; 2007 Oct; 19(10):431-6. PubMed ID: 17906345
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW
Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397
[TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
